Publication:
Calpastatin reduces calpain and caspase activation in methamphetamine-induced toxicity in human neuroblastoma SH-SY5Y cultured cells

dc.contributor.authorSuwanjang W.
dc.contributor.authorPhansuwan-Pujito P.
dc.contributor.authorGovitrapong P.
dc.contributor.authorChetsawang B.
dc.date.accessioned2021-04-05T03:33:58Z
dc.date.available2021-04-05T03:33:58Z
dc.date.issued2012
dc.date.issuedBE2555
dc.description.abstractMethamphetamine (METH) is an abused psychostimulant drug that can cause neurotoxicity to dopaminergic cells. It has been demonstrated that METH can induce caspase- and calpain-dependent death cascades. The purpose of the present study was to investigate the functional role of calpastatin, a specific endogenous calpain inhibitor protein, on caspase and calpain activation in METH-induced degeneration in neuroblastoma SH-SY5Y cell cultures. In this study, we found that METH significantly decreased cell viability, tyrosine hydroxylase phosphorylation and calpastatin levels. Supplementation of cells with exogenous calpastatin was able to reverse the toxic effect of METH on reduction in cell viability and tyrosine hydroxylase phosphorylation. METH also significantly increased calpain levels, the formation of calpain-specific breakdown products and cleaved caspase-3 levels; once again, these effects were diminished by pretreating the cells with calpastatin. These data suggest the contribution of calpastatin as a potential regulatory factor for calpain- and caspase-dependent death processes. © 2012 Elsevier Ireland Ltd.
dc.format.mimetypeapplication/pdf
dc.identifier.citationNeuroscience Letters. Vol 526, No.1 (2012), p.49-53
dc.identifier.doi10.1016/j.neulet.2012.07.066
dc.identifier.issn3043940
dc.identifier.other2-s2.0-84865627845
dc.identifier.urihttps://hdl.handle.net/20.500.14740/6971
dc.rights.holderScopus
dc.subject.otherCalpain
dc.subject.otherCalpastatin
dc.subject.otherCaspase 3
dc.subject.otherMethamphetamine
dc.subject.otherTyrosine 3 monooxygenase
dc.subject.otherArticle
dc.subject.otherCell culture
dc.subject.otherCell strain
dc.subject.otherCell viability
dc.subject.otherControlled study
dc.subject.otherEnzyme activation
dc.subject.otherHuman
dc.subject.otherHuman cell
dc.subject.otherNeuroblastoma
dc.subject.otherPriority journal
dc.subject.otherProtein blood level
dc.subject.otherProtein degradation
dc.subject.otherProtein phosphorylation
dc.subject.otherCalcium-Binding Proteins
dc.subject.otherCalpain
dc.subject.otherCaspase 3
dc.subject.otherCaspases
dc.subject.otherCell Line, Tumor
dc.subject.otherCell Survival
dc.subject.otherCentral Nervous System Stimulants
dc.subject.otherEnzyme Activation
dc.subject.otherHumans
dc.subject.otherMethamphetamine
dc.subject.otherNeuroblastoma
dc.subject.otherNeuroprotective Agents
dc.subject.otherPhosphorylation
dc.subject.otherTyrosine 3-Monooxygenase
dc.titleCalpastatin reduces calpain and caspase activation in methamphetamine-induced toxicity in human neuroblastoma SH-SY5Y cultured cells
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84865627845&doi=10.1016%2fj.neulet.2012.07.066&partnerID=40&md5=2d8a2ef1d039cfb3a49a19d8adc1634a

Files